← Leaderboards
Nathan Bass
University Of California San Francisco
$137,332
Attributed
$137,332
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$137,332 · 1
By mechanism
M01$137,332 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Thomas Sterling Scanlan$10,376,751
- Sunil D Kapila$6,386,827
- John D Baxter$8,180,256
- Holly A. Ingraham$28,179,658
- Cynthia J. Kenyon$14,520,817
Others in their field
Top investigators on “Benzazepines”
- Frank I Carroll · Research Triangle Institute$2,326,199
- Sarah Elizabeth Wengryniuk · Scripps Research Institute, The$1,197,788
- David Y Gin · University Of Illinois Urbana-Champaign$1,077,640
- Sherry R Chemler · Sloan-Kettering Institute For Cancer Res$934,098
- Margarita Ortiz-Marciales · University Of Puerto Rico At Humacao$932,864
- John L Neumeyer · Natural Pharmacia International, Inc.$777,365
Research focus
BenzazepinesClinical ResearchDosageHormone InhibitorHormone ReceptorHormone Regulation /Control MechanismHuman SubjectHuman Therapy EvaluationHyponatremiaLiver Disorder ChemotherapyLongitudinal Human StudyPlacebosVasopressins
Grant awards (4)
TRIAL OF OPC-41061 FOR TREATMENT OF HYPONATREMIA SECONDARY TO LIVER DISORDER$68,666
M01 · FY2002 · RR
TRIAL OF OPC-41061 FOR TREATMENT OF HYPONATREMIA SECONDARY TO LIVER DISORDER$68,666
M01 · FY2001 · RR
TRIAL OF OPC-41061 FOR TREATMENT OF HYPONATREMIA SECONDARY TO LIVER DISORDER$0
M01 · FY2001 · RR
TRIAL OF OPC-41061 FOR TREATMENT OF HYPONATREMIA SECONDARY TO LIVER DISORDER$0
M01 · FY2000 · RR